Pre-treatment with IL-6 potentiates β-cell death induced by pro-inflammatory cytokines

被引:2
|
作者
Oliveira, V. R. [1 ]
Paula, C. C. [1 ]
Taniguchi, S. [1 ]
Ortis, F. [1 ]
机构
[1] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
beta-cells; NF-kappa B; Pro-inflammatory cytokines; IL-6; ER stress and TUDCA; ENDOPLASMIC-RETICULUM STRESS; FACTOR-KAPPA-B; UNFOLDED PROTEIN RESPONSE; EXERCISE; INDUCTION; APOPTOSIS; CHAPERONE; MUSCLE; GENES; RAT;
D O I
10.1186/s12860-023-00476-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background Type I Diabetes mellitus (T1D) is characterized by a specific destruction of beta-cells by the immune system. During this process pro-inflammatory cytokines are released in the pancreatic islets and contribute for beta-cells demise. Cytokine-induced iNOS activation, via NF-kappa B, is implicated in induction of beta-cells death, which includes ER stress activation. Physical exercise has been used as an adjunct for better glycemic control in patients with T1D, since it is able to increase glucose uptake independent of insulin. Recently, it was observed that the release of IL-6 by skeletal muscle, during physical exercise, could prevent beta-cells death induced by pro-inflammatory cytokines. However, the molecular mechanisms involved in this beneficial effect on beta-cells are not yet completely elucidated. Our aim was to evaluate the effect of IL-6 on beta-cells exposed to pro-inflammatory cytokines. Results Pre-treatment with IL-6 sensitized INS-1E cells to cytokine-induced cell death, increasing cytokine-induced iNOS and Caspase-3 expression. Under these conditions, however, there was a decrease in cytokines-induced p-eIF2-alpha but not p-IRE1expression, proteins related to ER stress. To address if this prevention of adequate UPR response is involved in the increase in beta-cells death markers induced by IL-6 pre-treatment, we used a chemical chaperone (TUDCA), which improves ER folding capacity. Use of TUDCA increased cytokines-induced Caspase-3 expression and Bax/Bcl-2 ratio in the presence of IL-6 pre-treatment. However, there is no modulation of p-eIF2-alpha expression by TUDCA in this condition, with increase of CHOP expression. Conclusion Treatment with IL-6 alone is not beneficial for beta-cells, leading to increased cell death markers and impaired UPR activation. In addition, TUDCA has not been able to restore ER homeostasis or improve beta-cells viability under this condition, suggesting that other mechanisms may be involved.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Pre-treatment with IL-6 potentiates β-cell death induced by pro-inflammatory cytokines
    V. R. Oliveira
    C. C. Paula
    S. Taniguchi
    F. Ortis
    BMC Molecular and Cell Biology, 24
  • [2] Inhibition of histamine-induced human conjunctival cell release of pro-inflammatory cytokines IL-6 and IL-8
    Pauly, A
    Blondin, C
    Riancho, L
    Baudouin, C
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U530 - U530
  • [3] Inhibition of pro-inflammatory cytokines IL-6 and TNFα by Ajuga turkestanica phytochemicals
    Cheng, Diana M.
    Johnson, R. W.
    Raskin, I.
    Lila, M. A.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2008, 44 : S77 - S78
  • [4] IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo
    Choi, SE
    Choi, KM
    Yoon, IH
    Shin, JY
    Kim, JS
    Park, WY
    Han, DJ
    Kim, SC
    Ahn, C
    Kim, JY
    Hwang, ES
    Cha, CY
    Szot, GL
    Yoon, KH
    Park, CG
    TRANSPLANT IMMUNOLOGY, 2004, 13 (01) : 43 - 53
  • [5] Promoter polymorphisms in IL-6 gene influence pro-inflammatory cytokines for the risk of osteoarthritis
    Singh, Monica
    Mastana, Sarabjit
    Singh, Surinderpal
    Juneja, Pawan Kumar
    Kaur, Taranpal
    Singh, Puneetpal
    CYTOKINE, 2020, 127
  • [6] Analogues of boswellic acids as inhibitors of pro-inflammatory cytokines TNF-α and IL-6
    Sharma, Simmi
    Gupta, Shilpa
    Khajuria, Vidushi
    Bhagat, Asha
    Ahmed, Zabeer
    Shah, Bhahwal Ali
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (02) : 695 - 698
  • [7] Production of the pro-inflammatory cytokines IL-1β, IL-6 and IL-8 in active esophagitis
    Rieder, F
    Phillips, H
    West, GA
    Chalk, A
    Cooper, G
    Isenberg, G
    Ray, M
    Katz, JA
    Wong, RCK
    Post, A
    O'Shea, R
    Sivak, M
    Biancani, P
    Fiocchi, C
    GASTROENTEROLOGY, 2002, 122 (04) : A420 - A420
  • [8] Synthesis of Epoxyisoprostanes: Effects in Reducing Secretion of Pro-inflammatory Cytokines IL-6 and IL-12
    Egger, Julian
    Bretscher, Peter
    Freigang, Stefan
    Kopf, Manfred
    Carreira, Erick M.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2013, 52 (20) : 5382 - 5385
  • [9] BTEX exposure of pregnant women and associations with pro-inflammatory cytokines (IL-6 and TNF-α)
    Hashemi, Fallah
    Hamidinejad, Farahnaz Soleimani
    Hoepner, Lori
    Rafiee, Ata
    Abbasi, Alireza
    Hoseini, Mohammad
    AIR QUALITY ATMOSPHERE AND HEALTH, 2022, 15 (04): : 707 - 719
  • [10] Ticagrelor inhibits release of pro-inflammatory cytokines TNF and IL-6 during human endotoxaemia
    Thomas, M. R.
    Outteridge, S. N.
    Ecob, R.
    Sangha, G. K.
    Faulkner, R. E.
    West, L. E.
    Judge, H. M.
    Dockrell, D. H.
    Sabroe, I.
    Storey, R. F.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1170 - 1170